AKTHELIA Trademark

Trademark Overview

On Monday, February 14, 2022, a trademark application was filed for AKTHELIA with the United States Patent and Trademark Office. The USPTO has given the AKTHELIA trademark a serial number of 79336218. The federal status of this trademark filing is REGISTERED as of Tuesday, July 25, 2023. This trademark is owned by Akthelia Pharmaceuticals Ltd. The AKTHELIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services in the field of pharmaceutical development and research and design relating thereto, and technological consultation services and research in the technological field of pharmaceutical development of antimicrobials; and design for others in the field of pharmaceutical development and research; industrial analysis and research services in the field of pharmaceuticals; development, design and development of computer hardware and software; services limited to research and development within the pharmaceutical industry and related areas, namely, drug discovery services, the conducting of pre-clinical trials and clinical trial development
akthelia

General Information

Serial Number79336218
Word MarkAKTHELIA
Filing DateMonday, February 14, 2022
Status700 - REGISTERED
Status DateTuesday, July 25, 2023
Registration Number7117255
Registration DateTuesday, July 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements

Goods and ServicesScientific and technological services in the field of pharmaceutical development and research and design relating thereto, and technological consultation services and research in the technological field of pharmaceutical development of antimicrobials; and design for others in the field of pharmaceutical development and research; industrial analysis and research services in the field of pharmaceuticals; development, design and development of computer hardware and software; services limited to research and development within the pharmaceutical industry and related areas, namely, drug discovery services, the conducting of pre-clinical trials and clinical trial development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 24, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAkthelia Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressIS
Party NameAkthelia Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressIS
Party NameAkthelia Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressIS

Trademark Events

Event DateEvent Description
Sunday, November 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 25, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 25, 2023FINAL DISPOSITION PROCESSED
Wednesday, October 25, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 19, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 23, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 23, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, March 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 23, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 27, 2023REFUSAL PROCESSED BY IB
Friday, January 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 27, 2023REFUSAL PROCESSED BY MPU
Thursday, December 1, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 30, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 29, 2022ASSIGNED TO EXAMINER
Tuesday, March 29, 2022APPLICATION FILING RECEIPT MAILED
Thursday, March 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 23, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 17, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

akthelia development services research pharmaceutical field design technological clinical related areas